In This Section

Tobacco Products and Cancer Subcommittee

The AACR Tobacco Products and Cancer Subcommittee was convened in 2009 to foster scientific and policy initiatives to reduce the incidence of disease and mortality due to tobacco use. The subcommittee, consisting of experts in lung cancer, nicotine addiction, and smoking cessation, provides their subject matter expertise to the AACR Science Policy and Government Affairs Committee.

tobacco products and cancer Subcommittee Members

Printer-friendly version (pdf) 

Christine Lovly, MD, PhD
Chairperson

Associate Professor of Medicine
Co-Leader, Translational Research and Interventional Oncology Research Program
Vanderbilt University Medical Center
Nashville, TN

Suchitra Krishnan-Sarin, PhD
Vice Chairperson

Albert E. Kent Professor of Psychiatry
Chair, Human Investigations Committee II
Yale University School of Medicine
New Haven, CT

Christopher I. Amos, PhD
Director, Institute for Clinical and Translational Research
Associate Director, Quantitative Sciences
Daniel L. Duncan Comprehensive Cancer Center
Baylor College of Medicine
Houston, TX

Barbara A. Burtness, MD
Professor of Medicine
Co-Leader, Developmental Therapeutics
Yale University School of Medicine
Yale Cancer Center Yale
New Haven, CT

Paul M. Cinciripini, PhD
Professor and Chair, Department of Behavioral Science
Director, Tobacco Treatment Program
University of Texas MD Anderson Cancer Center
Houston, TX

Maciej L. Goniewicz, PharmD, PhD
Professor of Oncology
Department of Health Behavior
Division of Cancer Prevention and Population Sciences
Roswell Park Comprehensive Cancer Center
Buffalo, New York

Dorothy K. Hatsukami, PhD
Associate Director, Cancer Prevention
Forster Family Chair in Cancer Prevention
Masonic Cancer Center
Professor of Psychiatry
University of Minnesota
Minneapolis, MN

Stephanie R. Land, PhD, ex officio (NCI liaison)
Program Director and Statistician
Tobacco Control Research Branch
Behavioral Research Program
Division of Cancer Control and Population Sciences
National Cancer Institute
Bethesda, MD

Scott J. Leischow, PhD
Professor and Director of Clinical and Translational Science
College of Health Solutions
Arizona State University
Phoenix, Arizona

Timothy R. Rebbeck, PhD
Vincent L. Gregory, Jr. Professor of Cancer Prevention, Harvard TH Chan School of Public Health and Division of Population Sciences, Dana Farber Cancer Institute
Boston, MA

Nancy A. Rigotti, MD
Professor of Medicine
Professor of Population Medicine
Harvard Medical School
Director, Tobacco Research and Treatment Center Massachusetts General Hospital
Boston, MA

Peter G. Shields, MD
Deputy Director, Comprehensive Cancer Center
Professor, College of Medicine
Julius F. Stone Chair in Cancer Research
James Cancer Hospital
The Ohio State University Wexner Medical Center
Columbus, OH

Avrum E. Spira, MD, MSc
Director, Boston Medical Center Cancer Center
Professor of Medicine, Pathology and Bioinformatics Global Head, Johnson & Johnson Lung Cancer Initiative
Boston University School of Medicine
Boston, MA

Benjamin A. Toll, PhD
Professor of Public Health Sciences and Psychiatry
Vice Chair for Research, Public Health Sciences
Chief of Tobacco Cessation and Health Behaviors
Co-Director, Lung Cancer Screening Program
Director, MUSC Health Tobacco Treatment Program
Medical University of South Carolina
Charleston, SC

Kasisomayajula (Vish) Viswanath, PhD
Lee Kum Kee Professor of Health Communication
Harvard T. H. Chan School of Public Health
Dana-Farber Cancer Institute
Director, Center for Translational Health Communication Science, DFCI/HSPH
Director, Harvard Chan India Research Center
Co-Director, Lee Kum Sheung Center for Health and Happiness

Wendell Gray Yarbrough, MD, MMHC, FACS
Thomas J. Dark Distinguished Professor and Chair, Department of Otolaryngology/Head and Neck Surgery University of North Carolina Lineberger Comprehensive Cancer Center
Chapel Hill, NC

AACR STAFF CONTACT

Calais Prince, PhD
Associate Director, Science and Health Policy
Email